Very high response rates in previously untreated T-cell prolymphocytic leukaemia patients receiving Alemtuzumab (Campath-1H) therapy.

被引:0
|
作者
Dearden, CE
Matutes, E
Cazin, B
Ireland, R
Parreira, A
Lakhani, A
Catovsky, D
机构
[1] Royal Marsden Hosp, London SW3 6JJ, England
[2] Hosp C Huriez, Lille, France
[3] Queen Elizabeth Hosp, Woolwich, England
[4] Inst Oncol, Lisbon, Portugal
[5] Farnborough Hosp, Farnborough, Hants, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2378
引用
收藏
页码:644A / 644A
页数:1
相关论文
共 32 条
  • [31] Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
    Linea Natalie Toksvang
    Bodil Als-Nielsen
    Christopher Bacon
    Ruta Bertasiute
    Ximo Duarte
    Gabriele Escherich
    Elín Anna Helgadottir
    Inga Rinvoll Johannsdottir
    Ólafur G. Jónsson
    Piotr Kozlowski
    Cecilia Langenskjöld
    Kristi Lepik
    Riitta Niinimäki
    Ulrik Malthe Overgaard
    Mari Punab
    Riikka Räty
    Heidi Segers
    Inge van der Sluis
    Owen Patrick Smith
    Marion Strullu
    Goda Vaitkevičienė
    Hilde Skuterud Wik
    Mats Heyman
    Kjeld Schmiegelow
    BMC Cancer, 22
  • [32] Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol
    Toksvang, Linea Natalie
    Als-Nielsen, Bodil
    Bacon, Christopher
    Bertasiute, Ruta
    Duarte, Ximo
    Escherich, Gabriele
    Helgadottir, Elin Anna
    Johannsdottir, Inga Rinvoll
    Jonsson, Olafur G.
    Kozlowski, Piotr
    Langenskjold, Cecilia
    Lepik, Kristi
    Niinimaki, Riitta
    Overgaard, Ulrik Malthe
    Punab, Mari
    Raty, Riikka
    Segers, Heidi
    van der Sluis, Inge
    Smith, Owen Patrick
    Strullu, Marion
    Vaitkeviciene, Goda
    Wik, Hilde Skuterud
    Heyman, Mats
    Schmiegelow, Kjeld
    BMC CANCER, 2022, 22 (01)